Director, Inflation Reduction Act Strategy & Planning
AbbVie
June 29, 2026
Remote friendly (Mettawa, IL)
United States
$182,000 - $346,000 USD yearly
Market Access
Director, Inflation Reduction Act (IRA) Strategy & Planning
Key Responsibilities:
- Partner with Commercial Therapeutics, US Market Access, Global Commercial Development (GCD), Finance, Government Affairs, and Legal to assess IRA impacts on brands and pipeline assets.
- Serve as subject matter expert for therapeutic area leaders, Integrated Brand Teams (IBTs), and Asset Strategy Teams (ASTs) on IRA implications, timelines, and long-term impact.
- Develop and lead a structured framework to evaluate and risk-assess on-market and pipeline assets with IBTs and ASTs.
- Identify and prioritize IRA risks across the Long Range Plan (LRP) for each asset; lead cross-functional risk-navigating teams to drive mitigation strategies (life cycle management, negotiation alternatives, evidence generation).
- Support portfolio-wide risk stratification and segmentation to focus resources and innovation.
- Drive solutions that minimize IRA risk and maximize opportunities for patients and AbbVie.
Qualifications:
- Bachelor’s degree in business or related discipline.
- Master’s degree highly desirable.
- 12+ years progressive experience in highly regulated commercial business (pharma/healthcare strongly preferred).
Preferred Qualifications:
- Advanced degree in life sciences, business, public policy, or related field.
- Experience in portfolio risk management, market access, or strategic planning.
- Deep understanding of US healthcare policy and regulatory landscape; IRA knowledge highly valued.
- Strong leadership; proven ability to drive cross-functional teams and complex projects.
- Exceptional communication, negotiation, interpersonal skills; analytical thinking and problem-solving.
Benefits (if applicable):
- Paid time off; medical/dental/vision insurance; 401(k); long-term incentive programs.
Key Responsibilities:
- Partner with Commercial Therapeutics, US Market Access, Global Commercial Development (GCD), Finance, Government Affairs, and Legal to assess IRA impacts on brands and pipeline assets.
- Serve as subject matter expert for therapeutic area leaders, Integrated Brand Teams (IBTs), and Asset Strategy Teams (ASTs) on IRA implications, timelines, and long-term impact.
- Develop and lead a structured framework to evaluate and risk-assess on-market and pipeline assets with IBTs and ASTs.
- Identify and prioritize IRA risks across the Long Range Plan (LRP) for each asset; lead cross-functional risk-navigating teams to drive mitigation strategies (life cycle management, negotiation alternatives, evidence generation).
- Support portfolio-wide risk stratification and segmentation to focus resources and innovation.
- Drive solutions that minimize IRA risk and maximize opportunities for patients and AbbVie.
Qualifications:
- Bachelor’s degree in business or related discipline.
- Master’s degree highly desirable.
- 12+ years progressive experience in highly regulated commercial business (pharma/healthcare strongly preferred).
Preferred Qualifications:
- Advanced degree in life sciences, business, public policy, or related field.
- Experience in portfolio risk management, market access, or strategic planning.
- Deep understanding of US healthcare policy and regulatory landscape; IRA knowledge highly valued.
- Strong leadership; proven ability to drive cross-functional teams and complex projects.
- Exceptional communication, negotiation, interpersonal skills; analytical thinking and problem-solving.
Benefits (if applicable):
- Paid time off; medical/dental/vision insurance; 401(k); long-term incentive programs.